KIST-CUK research team develops vaccine platform applicable to various viruses

MERS, which struck South Korea in a 2015 outbreak, was caused by a coronavirus–the same family of viruses that is responsible for COVID-19. Recently, a Korean research team announced that it had developed a new vaccine platform using RNA-based adjuvants for the MERS coronavirus. The research team successfully conducted an experiment on nonhuman primates. It is expected that the new vaccine platform will soon be applicable to the development of a COVID-19 vaccine, an urgent global health priority.